HEADER SIGNALING PROTEIN 02-AUG-01 1JPL TITLE GGA3 VHS DOMAIN COMPLEXED WITH C-TERMINAL PEPTIDE FROM TITLE 2 CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA3; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: VHS DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR; COMPND 8 CHAIN: E, F, G, H; COMPND 9 FRAGMENT: C-TERMINAL PEPTIDE; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GGA3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHIS-PARALLEL2; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS PROTEIN-PEPTIDE COMPLEX; VHS DOMAIN; DXXLL SORTING SIGNAL, KEYWDS 2 SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.MISRA,R.PUERTOLLANO,J.S.BONIFACINO,J.H.HURLEY REVDAT 2 24-FEB-09 1JPL 1 VERSN REVDAT 1 27-FEB-02 1JPL 0 JRNL AUTH S.MISRA,R.PUERTOLLANO,Y.KATO,J.S.BONIFACINO, JRNL AUTH 2 J.H.HURLEY JRNL TITL STRUCTURAL BASIS FOR ACIDIC-CLUSTER-DILEUCINE JRNL TITL 2 SORTING-SIGNAL RECOGNITION BY VHS DOMAINS. JRNL REF NATURE V. 415 933 2002 JRNL REFN ISSN 0028-0836 JRNL PMID 11859375 JRNL DOI 10.1038/415933A REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 253695.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 62036 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6184 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8388 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 914 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5418 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.29000 REMARK 3 B22 (A**2) : 3.11000 REMARK 3 B33 (A**2) : 5.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.87 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.370 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.290 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.470 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 37.85 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JPL COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-AUG-01. REMARK 100 THE RCSB ID CODE IS RCSB014038. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 10.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97900, 0.97938, 0.95369 REMARK 200 MONOCHROMATOR : FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34790 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 10.300 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.30300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE/RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5M SODIUM/POTASSIUM PHOSPHATE, REMARK 280 200MM LITHIUM SULFATE, PH 10.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 54.15000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 62.65000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 54.15000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 62.65000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 8 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 THE AUTHORS HAVE GEL FILTRATION AND ANALYTICAL REMARK 300 ULTRACENTRIFUGATION DATA THAT SUGGEST THAT THE ASYMMETRIC REMARK 300 UNIT CONTAINS 4 BIOLOGICAL UNITS REMARK 300 (CHAINS A/E, B/F, C/G, D/H). THE AUTHORS THINK THE REMARK 300 APPARENT DIMER IN THE CRYSTAL IS DUE TO CRYSTALLIZATION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, H, G REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 162.45000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -62.65000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 129.20000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, H, G REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 108.30000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 125.30000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, H, G REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -54.15000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 62.65000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 129.20000 REMARK 350 REMARK 350 BIOMOLECULE: 8 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, H, G REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 108.30000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 125.30000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -64.60000 REMARK 350 REMARK 350 BIOMOLECULE: 9 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, H, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 10 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 201 REMARK 465 PRO A 158 REMARK 465 SER A 159 REMARK 465 PRO A 160 REMARK 465 PRO A 161 REMARK 465 PRO A 162 REMARK 465 ARG A 163 REMARK 465 PRO A 164 REMARK 465 LYS A 165 REMARK 465 ASN A 166 REMARK 465 PHE E 301 REMARK 465 HIS E 302 REMARK 465 ASP E 303 REMARK 465 ASP E 304 REMARK 465 GLY B 201 REMARK 465 ALA B 202 REMARK 465 ILE B 157 REMARK 465 PRO B 158 REMARK 465 SER B 159 REMARK 465 PRO B 160 REMARK 465 PRO B 161 REMARK 465 PRO B 162 REMARK 465 ARG B 163 REMARK 465 PRO B 164 REMARK 465 LYS B 165 REMARK 465 ASN B 166 REMARK 465 PHE F 301 REMARK 465 HIS F 302 REMARK 465 ASP F 303 REMARK 465 ASP F 304 REMARK 465 GLY C 201 REMARK 465 ALA C 202 REMARK 465 ILE C 157 REMARK 465 PRO C 158 REMARK 465 SER C 159 REMARK 465 PRO C 160 REMARK 465 PRO C 161 REMARK 465 PRO C 162 REMARK 465 ARG C 163 REMARK 465 PRO C 164 REMARK 465 LYS C 165 REMARK 465 ASN C 166 REMARK 465 PHE G 301 REMARK 465 HIS G 302 REMARK 465 ASP G 303 REMARK 465 ASP G 304 REMARK 465 GLY D 201 REMARK 465 PRO D 158 REMARK 465 SER D 159 REMARK 465 PRO D 160 REMARK 465 PRO D 161 REMARK 465 PRO D 162 REMARK 465 ARG D 163 REMARK 465 PRO D 164 REMARK 465 LYS D 165 REMARK 465 ASN D 166 REMARK 465 PHE H 301 REMARK 465 HIS H 302 REMARK 465 ASP H 303 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 58 O HOH A 206 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 101 -120.85 -126.79 REMARK 500 LEU A 125 73.02 -116.48 REMARK 500 GLU A 128 76.30 -108.56 REMARK 500 ASP E 306 146.57 174.48 REMARK 500 ASN B 21 130.09 -37.92 REMARK 500 TYR B 101 -96.93 -131.93 REMARK 500 ARG B 105 -5.10 -169.92 REMARK 500 GLN B 145 -70.81 -64.12 REMARK 500 THR B 155 24.69 -71.90 REMARK 500 ASP F 306 135.98 172.64 REMARK 500 LYS C 100 0.00 -69.98 REMARK 500 TYR C 101 -104.64 -133.84 REMARK 500 TYR D 101 -127.49 -126.59 REMARK 500 LEU D 125 68.80 -119.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH F 64 DISTANCE = 10.49 ANGSTROMS REMARK 525 HOH C 226 DISTANCE = 6.00 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ELK RELATED DB: PDB REMARK 900 VHS DOMAIN OF TOM1 (TARGET-OF-MYB1) REMARK 900 RELATED ID: 1DVP RELATED DB: PDB REMARK 900 VHS AND FYVE DOMAINS OF HRS REMARK 900 RELATED ID: 1JUQ RELATED DB: PDB REMARK 900 GGA3 VHS DOMAIN COMPLEXED WITH C-TERMINAL PEPTIDE FROM REMARK 900 CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR DBREF 1JPL A 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1JPL B 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1JPL C 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1JPL D 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1JPL E 301 312 UNP P11717 MPRI_HUMAN 2480 2491 DBREF 1JPL F 301 312 UNP P11717 MPRI_HUMAN 2480 2491 DBREF 1JPL G 301 312 UNP P11717 MPRI_HUMAN 2480 2491 DBREF 1JPL H 301 312 UNP P11717 MPRI_HUMAN 2480 2491 SEQADV 1JPL GLY A 201 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL ALA A 202 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE A 203 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL GLY A 204 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL SER A 205 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE A 1 UNP Q9NZ52 MET 1 MODIFIED RESIDUE SEQADV 1JPL MSE A 73 UNP Q9NZ52 MET 73 MODIFIED RESIDUE SEQADV 1JPL MSE A 123 UNP Q9NZ52 MET 123 MODIFIED RESIDUE SEQADV 1JPL MSE A 137 UNP Q9NZ52 MET 137 MODIFIED RESIDUE SEQADV 1JPL GLY B 201 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL ALA B 202 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE B 203 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL GLY B 204 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL SER B 205 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE B 1 UNP Q9NZ52 MET 1 MODIFIED RESIDUE SEQADV 1JPL MSE B 73 UNP Q9NZ52 MET 73 MODIFIED RESIDUE SEQADV 1JPL MSE B 123 UNP Q9NZ52 MET 123 MODIFIED RESIDUE SEQADV 1JPL MSE B 137 UNP Q9NZ52 MET 137 MODIFIED RESIDUE SEQADV 1JPL GLY C 201 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL ALA C 202 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE C 203 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL GLY C 204 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL SER C 205 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE C 1 UNP Q9NZ52 MET 1 MODIFIED RESIDUE SEQADV 1JPL MSE C 73 UNP Q9NZ52 MET 73 MODIFIED RESIDUE SEQADV 1JPL MSE C 123 UNP Q9NZ52 MET 123 MODIFIED RESIDUE SEQADV 1JPL MSE C 137 UNP Q9NZ52 MET 137 MODIFIED RESIDUE SEQADV 1JPL GLY D 201 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL ALA D 202 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE D 203 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL GLY D 204 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL SER D 205 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1JPL MSE D 1 UNP Q9NZ52 MET 1 MODIFIED RESIDUE SEQADV 1JPL MSE D 73 UNP Q9NZ52 MET 73 MODIFIED RESIDUE SEQADV 1JPL MSE D 123 UNP Q9NZ52 MET 123 MODIFIED RESIDUE SEQADV 1JPL MSE D 137 UNP Q9NZ52 MET 137 MODIFIED RESIDUE SEQRES 1 A 171 GLY ALA MSE GLY SER MSE ALA GLU ALA GLU GLY GLU SER SEQRES 2 A 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 A 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 A 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 A 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 A 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MSE SEQRES 7 A 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 A 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 A 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 A 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MSE ALA LEU SEQRES 11 A 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MSE LEU SEQRES 12 A 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 A 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 A 171 LYS ASN SEQRES 1 E 12 PHE HIS ASP ASP SER ASP GLU ASP LEU LEU HIS ILE SEQRES 1 B 171 GLY ALA MSE GLY SER MSE ALA GLU ALA GLU GLY GLU SER SEQRES 2 B 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 B 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 B 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 B 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 B 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MSE SEQRES 7 B 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 B 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 B 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 B 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MSE ALA LEU SEQRES 11 B 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MSE LEU SEQRES 12 B 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 B 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 B 171 LYS ASN SEQRES 1 F 12 PHE HIS ASP ASP SER ASP GLU ASP LEU LEU HIS ILE SEQRES 1 C 171 GLY ALA MSE GLY SER MSE ALA GLU ALA GLU GLY GLU SER SEQRES 2 C 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 C 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 C 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 C 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 C 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MSE SEQRES 7 C 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 C 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 C 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 C 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MSE ALA LEU SEQRES 11 C 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MSE LEU SEQRES 12 C 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 C 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 C 171 LYS ASN SEQRES 1 G 12 PHE HIS ASP ASP SER ASP GLU ASP LEU LEU HIS ILE SEQRES 1 D 171 GLY ALA MSE GLY SER MSE ALA GLU ALA GLU GLY GLU SER SEQRES 2 D 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 D 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 D 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 D 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 D 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MSE SEQRES 7 D 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 D 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 D 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 D 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MSE ALA LEU SEQRES 11 D 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MSE LEU SEQRES 12 D 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 D 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 D 171 LYS ASN SEQRES 1 H 12 PHE HIS ASP ASP SER ASP GLU ASP LEU LEU HIS ILE MODRES 1JPL MSE A 203 MET SELENOMETHIONINE MODRES 1JPL MSE A 1 MET SELENOMETHIONINE MODRES 1JPL MSE A 73 MET SELENOMETHIONINE MODRES 1JPL MSE A 123 MET SELENOMETHIONINE MODRES 1JPL MSE A 137 MET SELENOMETHIONINE MODRES 1JPL MSE B 203 MET SELENOMETHIONINE MODRES 1JPL MSE B 1 MET SELENOMETHIONINE MODRES 1JPL MSE B 73 MET SELENOMETHIONINE MODRES 1JPL MSE B 123 MET SELENOMETHIONINE MODRES 1JPL MSE B 137 MET SELENOMETHIONINE MODRES 1JPL MSE C 203 MET SELENOMETHIONINE MODRES 1JPL MSE C 1 MET SELENOMETHIONINE MODRES 1JPL MSE C 73 MET SELENOMETHIONINE MODRES 1JPL MSE C 123 MET SELENOMETHIONINE MODRES 1JPL MSE C 137 MET SELENOMETHIONINE MODRES 1JPL MSE D 203 MET SELENOMETHIONINE MODRES 1JPL MSE D 1 MET SELENOMETHIONINE MODRES 1JPL MSE D 73 MET SELENOMETHIONINE MODRES 1JPL MSE D 123 MET SELENOMETHIONINE MODRES 1JPL MSE D 137 MET SELENOMETHIONINE HET MSE A 203 8 HET MSE A 1 8 HET MSE A 73 8 HET MSE A 123 8 HET MSE A 137 8 HET MSE B 203 8 HET MSE B 1 8 HET MSE B 73 8 HET MSE B 123 8 HET MSE B 137 8 HET MSE C 203 8 HET MSE C 1 8 HET MSE C 73 8 HET MSE C 123 8 HET MSE C 137 8 HET MSE D 203 8 HET MSE D 1 8 HET MSE D 73 8 HET MSE D 123 8 HET MSE D 137 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 20(C5 H11 N O2 SE) FORMUL 9 HOH *237(H2 O) HELIX 1 1 MSE A 203 ALA A 2 5 5 HELIX 2 2 GLU A 3 ASN A 18 1 16 HELIX 3 3 ASP A 25 GLU A 39 1 15 HELIX 4 4 GLU A 41 GLN A 55 1 15 HELIX 5 5 GLN A 58 CYS A 76 1 19 HELIX 6 6 CYS A 76 GLY A 85 1 10 HELIX 7 7 LYS A 86 SER A 98 1 13 HELIX 8 8 TYR A 101 VAL A 106 5 6 HELIX 9 9 SER A 107 LEU A 125 1 19 HELIX 10 10 GLU A 128 GLN A 141 1 14 HELIX 11 11 GLY B 204 ALA B 2 5 4 HELIX 12 12 GLU B 3 THR B 17 1 15 HELIX 13 13 ASP B 25 GLU B 39 1 15 HELIX 14 14 GLU B 41 GLN B 55 1 15 HELIX 15 15 GLN B 58 CYS B 76 1 19 HELIX 16 16 CYS B 76 GLY B 85 1 10 HELIX 17 17 LYS B 86 SER B 98 1 13 HELIX 18 18 LEU B 102 VAL B 106 5 5 HELIX 19 19 SER B 107 LEU B 125 1 19 HELIX 20 20 GLU B 128 GLN B 141 1 14 HELIX 21 21 GLY C 204 ALA C 2 5 4 HELIX 22 22 GLU C 3 THR C 17 1 15 HELIX 23 23 ASP C 25 GLU C 39 1 15 HELIX 24 24 GLU C 41 GLN C 55 1 15 HELIX 25 25 GLN C 58 CYS C 76 1 19 HELIX 26 26 CYS C 76 GLY C 85 1 10 HELIX 27 27 LYS C 86 SER C 98 1 13 HELIX 28 28 LEU C 102 VAL C 106 5 5 HELIX 29 29 SER C 107 LEU C 125 1 19 HELIX 30 30 GLU C 128 GLN C 141 1 14 HELIX 31 31 MSE D 203 ALA D 2 5 5 HELIX 32 32 GLU D 3 THR D 17 1 15 HELIX 33 33 ASP D 25 GLU D 39 1 15 HELIX 34 34 GLU D 41 GLN D 55 1 15 HELIX 35 35 GLN D 58 CYS D 76 1 19 HELIX 36 36 CYS D 76 GLY D 85 1 10 HELIX 37 37 LYS D 86 SER D 98 1 13 HELIX 38 38 LEU D 102 VAL D 106 5 5 HELIX 39 39 SER D 107 LEU D 125 1 19 HELIX 40 40 GLU D 128 GLN D 141 1 14 LINK N MSE A 1 C SER A 205 1555 1555 1.33 LINK C MSE A 1 N ALA A 2 1555 1555 1.33 LINK C CYS A 72 N MSE A 73 1555 1555 1.33 LINK C MSE A 73 N LYS A 74 1555 1555 1.33 LINK C THR A 122 N MSE A 123 1555 1555 1.33 LINK C MSE A 123 N ALA A 124 1555 1555 1.33 LINK C HIS A 136 N MSE A 137 1555 1555 1.32 LINK C MSE A 137 N LEU A 138 1555 1555 1.33 LINK C ALA A 202 N MSE A 203 1555 1555 1.33 LINK C MSE A 203 N GLY A 204 1555 1555 1.33 LINK N MSE B 1 C SER B 205 1555 1555 1.33 LINK C MSE B 1 N ALA B 2 1555 1555 1.33 LINK C CYS B 72 N MSE B 73 1555 1555 1.33 LINK C MSE B 73 N LYS B 74 1555 1555 1.33 LINK C THR B 122 N MSE B 123 1555 1555 1.33 LINK C MSE B 123 N ALA B 124 1555 1555 1.33 LINK C HIS B 136 N MSE B 137 1555 1555 1.33 LINK C MSE B 137 N LEU B 138 1555 1555 1.33 LINK C MSE B 203 N GLY B 204 1555 1555 1.33 LINK N MSE C 1 C SER C 205 1555 1555 1.33 LINK C MSE C 1 N ALA C 2 1555 1555 1.33 LINK C CYS C 72 N MSE C 73 1555 1555 1.33 LINK C MSE C 73 N LYS C 74 1555 1555 1.33 LINK C THR C 122 N MSE C 123 1555 1555 1.33 LINK C MSE C 123 N ALA C 124 1555 1555 1.33 LINK C HIS C 136 N MSE C 137 1555 1555 1.32 LINK C MSE C 137 N LEU C 138 1555 1555 1.33 LINK C MSE C 203 N GLY C 204 1555 1555 1.33 LINK C MSE D 1 N ALA D 2 1555 1555 1.33 LINK N MSE D 1 C SER D 205 1555 1555 1.33 LINK C CYS D 72 N MSE D 73 1555 1555 1.33 LINK C MSE D 73 N LYS D 74 1555 1555 1.33 LINK C THR D 122 N MSE D 123 1555 1555 1.33 LINK C MSE D 123 N ALA D 124 1555 1555 1.33 LINK C HIS D 136 N MSE D 137 1555 1555 1.33 LINK C MSE D 137 N LEU D 138 1555 1555 1.33 LINK C ALA D 202 N MSE D 203 1555 1555 1.33 LINK C MSE D 203 N GLY D 204 1555 1555 1.33 CRYST1 108.300 125.300 64.600 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009234 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007981 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015480 0.00000